Peripheral MR Angiography

Magnetic Resonance Imaging Clinics of North America

Volumn 20, Issue 4, 2012, Pages 761-776

  Kramer, J Harald ^a,b   Grist, Thomas M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiovascular disease; Contrast enhanced MRA; Magnetic Resonance Imaging; Peripheral arteries

Indexed keywords

GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBOGRAPHY; REVIEW; THREE DIMENSIONAL IMAGING; ARTERY; METHODOLOGY; PATHOLOGY;

ARTERIES; CONTRAST MEDIA; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL ARTERIAL DISEASE;

EID: 84867885543     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2012.08.002     Document Type: Review

References (54)

1. Minino A. Death: final data for 2008. Natl Vital Stat Rep 2011, 59(10):1-126.
2. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5-S67.
3. Weckbach S., Findeisen H.M., Schoenberg S.O., et al. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Invest Radiol 2009, 44(4):242-250.
4. Dormandy J., Heeck L., Vig S. Acute limb ischemia. Semin Vasc Surg 1999, 12(2):148-153.
5. Diehm C., Kareem S., Lawall H. Epidemiology of peripheral arterial disease. Vasa 2004, 33(4):183-189.
6. Cowper S.E. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol 2007, 23:131-154.
7. Thomsen H.S. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 2006, 16(12):2619-2621.
8. Green D., Parker D. CTA and MRA: visualization without catheterization. Semin Ultrasound CT MR 2003, 24(4):185-191.
9. Pintaske J., Martirosian P., Graf H., et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006, 41(3):213-221.
10. Rohrer M., Bauer H., Mintorovitch J., et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005, 40(11):715-724.
11. Goyen M., Herborn C.U., Vogt F.M., et al. Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn Reson Imaging 2003, 17(5):565-571.
12. Goyen M., Lauenstein T.C., Herborn C.U., et al. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001, 14(5):602-607.
13. Gregor M., Tombach B., Hentsch A., et al. Peripheral run-off CE-MRA with a 1.0 molar gadolinium chelate (Gadovist) with intraarterial DSA comparison. Acad Radiol 2002, 9(Suppl 2):S398-S400.
14. Kramer H., Michaely H.J., Requardt M., et al. Effects of injection rate and dose on image quality in time-resolved magnetic resonance angiography (MRA) by using 1.0M contrast agents. Eur Radiol 2007, 17(6):1394-1402.
15. Klessen C., Hein P.A., Huppertz A., et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 2007, 42(9):659-664.
16. Hoffmann U., Loewe C., Bernhard C., et al. MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience. J Magn Reson Imaging 2002, 15(4):429-437.
17. Nikolaou K., Kramer H., Grosse C., et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology 2006, 241(3):861-872.
18. Tombach B., Reimer P., Bremer C., et al. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed 2004, 17(7):500-506.
19. Fink C., Ley S., Schoenberg S.O., et al. Magnetic resonance imaging of acute pulmonary embolism. Eur Radiol 2007, 17(10):2546-2553.
20. Goyen M., Debatin J.F., Ruehm S.G. Peripheral magnetic resonance angiography. Top Magn Reson Imaging 2001, 12(5):327-335.
21. Leiner T. Magnetic resonance angiography of abdominal and lower extremity vasculature. Top Magn Reson Imaging 2005, 16(1):21-66.
22. Marchal G., Michiels J., Bosmans H., et al. Contrast-enhanced MRA of the brain. J Comput Assist Tomogr 1992, 16(1):25-29.
23. Bongartz G.M., Boos M., Winter K., et al. Clinical utility of contrast-enhanced MR angiography. Eur Radiol 1997, 7(Suppl 5):178-186.
24. Westenberg J.J., Wasser M.N., van der Geest R.J., et al. Scan optimization of gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injections and in vitro validation of stenosis quantification. Magn Reson Imaging 1999, 17(1):47-57.
25. Hood M.N., Ho V.B., Foo T.K., et al. High-resolution gadolinium-enhanced 3D MRA of the infrapopliteal arteries. Lessons for improving bolus-chase peripheral MRA. Magn Reson Imaging 2002, 20(7):543-549.
26. Czum J.M., Ho V.B., Hood M.N., et al. Bolus-chase peripheral 3D MRA using a dual-rate contrast media injection. J Magn Reson Imaging 2000, 12(5):769-775.
27. Kramer H., Michaely H.J., Matschl V., et al. High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla. Invest Radiol 2007, 42(6):477-483.
28. Kramer H., Michaely H.J., Reiser M.F., et al. Peripheral magnetic resonance angiography at 3.0 T. Top Magn Reson Imaging 2007, 18(2):135-138.
29. Bammer R., Schoenberg S.O. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 2004, 15(3):129-158.
30. Blaimer M., Breuer F., Mueller M., et al. SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method. Top Magn Reson Imaging 2004, 15(4):223-236.
31. Nokes S.R. Elliptic centric contrast enhanced MRA provides high resolution, noninvasive evaluation of the carotid/vertebral arteries. J Ark Med Soc 2001, 98(3):83-88.
32. Meissner O.A., Rieger J., Weber C., et al. Critical limb ischemia: hybrid MR angiography compared with DSA. Radiology 2005, 235(1):308-318.
33. Hany T.F., Pfammatter T., Debatin J.F. Schweiz Med Wochenschr 1998, 128(14):544-551. [in German].
34. Berg F., Bangard C., Bovenschulte H., et al. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography. Invest Radiol 2008, 43(9):642-649.
35. Thornton F.J., Du J., Suleiman S.A., et al. High-resolution, time-resolved MRA provides superior definition of lower-extremity arterial segments compared to 2D time-of-flight imaging. J Magn Reson Imaging 2006, 24(2):362-370.
36. Carroll T.J., Korosec F.R., Swan J.S., et al. The effect of injection rate on time-resolved contrast-enhanced peripheral MRA. J Magn Reson Imaging 2001, 14(4):401-410.
37. Carroll T.J., Korosec F.R., Swan J.S., et al. Method for rapidly determining and reconstructing the peak arterial frame from a time-resolved CE-MRA exam. Magn Reson Med 2000, 44(5):817-820.
38. Zenge M.O., Vogt F.M., Brauck K., et al. High-resolution continuously acquired peripheral MR angiography featuring partial parallel imaging GRAPPA. Magn Reson Med 2006, 56(4):859-865.
39. Cronqvist M., Stahlberg F., Larsson E.M., et al. Evaluation of time-of-flight and phase-contrast MRA sequences at 1.0 T for diagnosis of carotid artery disease. I. A phantom and volunteer study. Acta Radiol 1996, 37(3 Pt 1):267-277.
40. Davis W.L., Warnock S.H., Harnsberger H.R., et al. Intracranial MRA: single volume vs. multiple thin slab 3D time-of-flight acquisition. J Comput Assist Tomogr 1993, 17(1):15-21.
41. Yucel E.K., Kaufman J.A., Geller S.C., et al. Atherosclerotic occlusive disease of the lower extremity: prospective evaluation with two-dimensional time-of-flight MR angiography. Radiology 1993, 187(3):637-641.
42. Miyazaki M., Lee V.S. Nonenhanced MR angiography. Radiology 2008, 248(1):20-43.
43. Miyazaki M., Sugiura S., Tateishi F., et al. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 2000, 12(5):776-783.
44. Kramer H., Zenge M., Schmitt P., et al. Peripheral magnetic resonance angiography (MRA) with continuous table movement at 3.0 T: initial experience compared with step-by-step MRA. Invest Radiol 2008, 43(9):627-634.
45. Zenge M.O., Ladd M.E., Quick H.H. Novel reconstruction method for three-dimensional axial continuously moving table whole-body magnetic resonance imaging featuring autocalibrated parallel imaging GRAPPA. Magn Reson Med 2009, 61(4):867-873.
46. Kramer H., Runge V.M., Morelli J.N., et al. Magnetic resonance angiography of the carotid arteries: comparison of unenhanced and contrast enhanced techniques. Eur Radiol 2011, 21(8):1667-1676.
47. Edelman R.R., Sheehan J.J., Dunkle E., et al. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med 2010, 63(4):951-958.
48. Hodnett P.A., Koktzoglou I., Davarpanah A.H., et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology 2011, 260(1):282-293.
49. Sostman H.D. MRA for diagnosis of venous thromboembolism. Q J Nucl Med 2001, 45(4):311-323.
50. Hany T.F., Carroll T.J., Omary R.A., et al. Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography-initial results. Radiology 2001, 221(1):266-272.
51. Maki J.H., Wang M., Wilson G.J., et al. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging 2009, 30(5):1085-1092.
52. Anzidei M., Napoli A., Zaccagna F., et al. First-pass and high-resolution steady-state magnetic resonance angiography of the peripheral arteries with gadobenate dimeglumine: an assessment of feasibility and diagnostic performance. Invest Radiol 2011, 46(5):307-316.
53. Voth M., Haneder S., Huck K., et al. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T. Invest Radiol 2009, 44(9):627-633.
54. Janka R., Wenkel E., Fellner C., et al. Magnetic resonance angiography of the peripheral vessels in patients with peripheral arterial occlusive disease: when is an additional conventional angiography required?. Cardiovasc Intervent Radiol 2006, 29(2):220-229.